Will Dendreon Break FDA and Wall Street Stranglehold on Cancer?

by RoryKearney | April 27, 2009 at 04:31 am

1250 views | 20 Recommendations | 0 comments

Tomorrow, April 28, 2009, at long last the day of reckoning for Immunotherapy is upon us. Dendreon will present its statistically significant Impact trial results on Provenge at the American Urological Association.

Guess what folks? IT WORKS! Not only does it work, but it works much better than anything to date.

This development is so significant, it is going to start a revolution in disease management.

One day it will rank right up there with the Salk Vaccine.

However this is no time for celebration.

Our fight is far from over.

Once the data is released, it will still take another year until approval if the FDA doesn't grow a heart, and answer the Care To Live Citizens' Petition that has been languishing at the FDA since August of 2007, and immediately reconsider their corrupt decision, foisted upon them by the Chemo Cartel, and grant access to men who are in dire need of this non toxic, non invasive immunotherapy that retrains the immune system to fight off the cancer.

Once the numbers are released join us as we kick into high gear to try to expedite the approval process.

TED GIRGUS NEEDS PROVENGE YESTERDAY!

* * * * *

Overstock CEO Patrick Byrne just wrote an incredible story covering part of the Dendreon Debacle. Thanks Patrick. You are the best!

Read it here >> Dendreon’s Cancer Researchers vs. Hedge Funds & The Bootlick Journalists (or, What’s 18 Million Fails Among Friends?)

Excerpt

"Given that, one may then ask of those journalists who defend the right of hedge funds to destroy firms they wish to destroy, that is to say, of DowJones’ Carol Remond and Karen Richardson, of Fortune Magazine’s Roddy Boyd and Bethany McLean (now at Vanity Fair), of New York Times’ Floyd Norris and Joe Nocera, of Herb Greenberg hiding behind vapid emails and Dave Kansas hiding under his desk, of NY Post/Portfolio Magazine’s Dan “Crusher” Colarusso and CNBC’s Jim Cramer the Crook: Do you get it now? Do you understand why illegal stock manipulation is wrong, and can impose costs on society it was your duty as journalists to explore? You purveyors of reportorial Velveeta, you lazy and captured, half-educated and dim-witted, snarky, insufferable, conformist and indolent pseudo-intellectual lickspittles, do you get it now? You are sell-out journalists who grovelled to your sources, missed the story of your careers, and in the eyes of an increasing fraction of the public, rank just below pedophile priests."

If this essay concerns you, and you wish to help, then:

1) email it to a dozen friends;

2) email The Story of Deep Capture to a dozen friends;

3) go here for additional suggestions: “So You Say You Want a Revolution?“

* * * * *

Provenge has already been before an FDA Advisory Committee which voted it 17 to 0 safe and 13 to 4 substantial evidence of efficacy. Several of the naysayers were severely conflicted chemo pushers, some with undisclosed financial conflicts. Howard Scher, Maha Hussain, Thomas R Fleming and Richard Pazdur colluded against Provenge, to stop it from being approved due to their own selfish interests.

Please visit http://www.CareToLive.com to learn more about this incredible Immunotherapy and join us in our fight.

One day we hope to see immunotherapy used to treat breast cancer, lung cancer, colon cancer etc.

Some men who have taken the 3 treatments are alive and doing well, over 7 years later.

1 in 6 men get prostate cancer.

30,000 American men go on to die from it every year.

With Provenge, many men would still be alive.

We, at Care To Live, have been fighting tooth and nail for the acceptance of this treatment for several years.

Provenge is an immunotherapy that has been delayed for 2 years by the corrupt FDA, Wall Street, Captured Journalists, and the Chemo Cartel.

The stock has been naked shorted out the wazoo since a corrupt hedge fund whispered to the captured press, that it doesn't work, years before that information was even knowable.

Last week we went to Washington DC to Michael Milken's Prostate Cancer Foundation Roundtable Discussion and Mike Kearney, interviewed one of the conflicted naysayers. You can read it here>>http://www.investorvillage.com/smbd.asp?mb=971&mn=265065&pt=msg&mid=7121263

Mike did a great job, and got two Prostate Cancer Foundation big shots, to admit on film, that if the data is there, the PCF will throw its support behind approval. Until now, the PCF, the world's larget foundation for men with prostate cancer, which also runs Faster Cures, has not given Care To Live's fight for Provenge the time of day. We at CTL believe Provenge would already be available if they had supported it, as it is their mandate to do. We are going to call them once again, to help us get approval NOW!

Come on Milken. Call our attorney Kerry Donahue. Let's work together to get Provenge to the men.

Join Operation Accelerate Approval!

Join Care To Live

Please feel free to reproduce this information early and often.

TIA

http://www.CareToLive.com

Other Now Public Stories by Rory Kearney